Agger Mette Kirstine, director of TRVI - Past Performance as of 05/25/19. Total 2 Records. Link to Thomson Financial
Buy(P) /
Sell(S)
P/S date Filed Date Company Symbol Insider Relationship Share Amt. Unit Price Total Proceeds Shares Owned Return(1m) Details
P 2019-05-09 2019-05-13 17:02:49.0 Trevi Therapeutics, Inc. TRVI Agger Mette Kirstine director 375,000 $10.00 $3,750,000.00 1,151,540 view
P 2017-11-21 2018-02-13 17:39:56.0 scPharmaceuticals Inc. SCPH Agger Mette Kirstine director 10% owner 654,762 $14.00 $9,166,670.00 3,183,990 view
* Filed by insider as open market transaction, but marked as private transaction by insidercow's proprietary method